Amy Elizabeth Comander, M.D.

Concepts (29)

Back to Profile

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name	Number of Publications	Most Recent Publication	Publications by All Authors	Concept Score	Why?
Topotecan	1	2007	130	0.270	Why?
Organoplatinum Compounds	1	2007	405	0.250	Why?
Fallopian Tube Neoplasms	1	2007	329	0.230	Why?
Cystadenocarcinoma, Serous	1	2007	480	0.200	Why?
Peritoneal Neoplasms	1	2007	706	0.180	Why?
Genes, BRCA1	2	2011	753	0.130	Why?
Ovarian Neoplasms	1	2007	4904	0.090	Why?
Heterozygote	2	2011	2796	0.070	Why?
Carcinosarcoma	1	2007	106	0.070	Why?
Antineoplastic Agents	1	2007	13631	0.060	Why?
Receptors, Estrogen	1	2010	2242	0.050	Why?
Remission Induction	1	2007	2413	0.050	Why?
Administration, Oral	1	2007	4016	0.040	Why?
Feasibility Studies	1	2007	5300	0.030	Why?
Breast Neoplasms	2	2011	21069	0.030	Why?
Mutation	2	2011	30192	0.020	Why?
Chemotherapy, Adjuvant	1	2011	3542	0.010	Why?
Aged	3	2011	171163	0.010	Why?
Neoplasm Metastasis	1	2011	4882	0.010	Why?
Middle Aged	3	2011	223016	0.010	Why?
Adult	3	2011	223088	0.010	Why?
Recurrence	1	2011	8492	0.010	Why?
Survival Rate	1	2011	12822	0.010	Why?
Female	3	2011	396141	0.010	Why?
Case-Control Studies	1	2010	22228	0.010	Why?
Prognosis	1	2011	29890	0.010	Why?
Humans	3	2011	765926	0.010	Why?
Treatment Outcome	1	2011	65194	0.000	Why?
Risk Factors	1	2010	74850	0.000	Why?

Comander's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (29)

Explore

Co-Authors (8)

Explore

Similar People (60)

Explore

Same Department

Explore

Physical Neighbors